Case 1:22-cv-00252-MSG Document 210-5 Filed 02/02/24 Page 1 of 12 PageID #: 14275
`Case 1:22-cv-00252-MSG Document 210-5 Filed 02/02/24 Page 1 of 12 PagelD #: 14275
`
`
`
`
`EXHIBIT E
`EXHIBIT E
`
`
`
`
`Case 1:22-cv-00252-MSG Document 210-5 Filed 02/02/24 Page 1 of 12 PagelD #: 14275
`
`
`
`
`EXHIBIT E
`EXHIBIT E
`
`
`
`
`
`1/11/24, 7:35 PM
`
`mRNA medicines we are currently developing
`Case 1:22-cv-00252-MSG Document 210-5 Filed 02/02/24 Page 2 of 12 PageID #: 14276
`
`USA English
`
`https://www.modernatx.com/en-US/research/product-pipeline
`
`1/11
`
`SPIKEVAX (COVID-19 Vaccine, mRNA) Now Approved! Learn more
`Filter:
`Research
`browse:
`Our mRNA pipeline shows the progress we’re making on clinical programs
`currently in development to create mRNA medicines for a wide range of
`diseases and conditions.
`All Categories
`Therapeutic Areas mRNA pipeline
`Clinical trials Moderna Genomics
`Search
`
`
`1/11/24, 7:35 PM
`
`mRNA medicines we are currently developing
`Case 1:22-cv-00252-MSG Document 210-5 Filed 02/02/24 Page 3 of 12 PageID #: 14277
`
`https://www.modernatx.com/en-US/research/product-pipeline
`
`2/11
`
`INFECTIOUS DISEASE VACCINES
`COVID-19 vaccine
`Spikevax®
`Commercial
`Moderna rights: Worldwide
`COVID-19 vaccine
`Next generation (2-5 ºC)
`mRNA-1283
`Phase 3
`Moderna rights: Worldwide
`Flu vaccine
`mRNA-1010
`Phase 3
`Moderna rights: Worldwide
`Flu vaccine
`mRNA-1020
`Phase 2
`Moderna rights: Worldwide
`Flu vaccine
`mRNA-1030
`Phase 2
`ADULTS
`
`
`1/11/24, 7:35 PM
`
`mRNA medicines we are currently developing
`Case 1:22-cv-00252-MSG Document 210-5 Filed 02/02/24 Page 4 of 12 PageID #: 14278
`
`https://www.modernatx.com/en-US/research/product-pipeline
`
`3/11
`
`Moderna rights: Worldwide
`Flu vaccine
`mRNA-1011
`Phase 2
`Moderna rights: Worldwide
`Flu vaccine
`mRNA-1012
`Phase 2
`Moderna rights: Worldwide
`Older adults respiratory syncytial virus (RSV) vaccine
`mRNA-1345
`Phase 3
`Moderna rights: Worldwide
`Flu + COVID vaccine
`mRNA-1083
`Phase 3
`Moderna rights: Worldwide
`Flu + COVID + RSV vaccine
`mRNA-1230
`Phase 1
`Moderna rights: Worldwide
`
`
`1/11/24, 7:35 PM
`
`mRNA medicines we are currently developing
`Case 1:22-cv-00252-MSG Document 210-5 Filed 02/02/24 Page 5 of 12 PageID #: 14279
`
`https://www.modernatx.com/en-US/research/product-pipeline
`
`4/11
`
`Flu + RSV vaccine
`mRNA-1045
`Phase 1
`Moderna rights: Worldwide
`Endemic HCoV vaccine
`mRNA-1287
`Preclinical Development
`Moderna rights: Worldwide
`Pandemic Flu
`mRNA-1018
`Phase 1
`Moderna rights: Worldwide
`RSV + hMPV vaccine
`mRNA-1365
`Phase 1
`Moderna rights: Worldwide
`COVID-19 (adolescents)
`TeenCOVE
`mRNA-1273.815
`Commercial
`Moderna rights: Worldwide
`ADOLESCENTS AND PEDIATRICS
`
`
`1/11/24, 7:35 PM
`
`mRNA medicines we are currently developing
`Case 1:22-cv-00252-MSG Document 210-5 Filed 02/02/24 Page 6 of 12 PageID #: 14280
`
`https://www.modernatx.com/en-US/research/product-pipeline
`
`5/11
`
`COVID-19 vaccine (pediatrics)
`KidCOVE
`mRNA-1273.815
`Commercial
`Moderna rights: Worldwide
`Pediatric RSV vaccine
`mRNA-1345
`Phase 1
`Moderna rights: Worldwide
`LATENT & PUBLIC HEALTH VACCINES
`CMV vaccine
`mRNA-1647
`Phase 3
`Moderna rights: Worldwide
`EBV vaccine (to prevent infectious mononucleosis)
`mRNA-1189
`Phase 1
`Moderna rights: Worldwide
`EBV vaccine (to prevent long term EBV sequelae)
`mRNA-1195
`Phase 1
`LATENT VACCINES
`
`
`1/11/24, 7:35 PM
`
`mRNA medicines we are currently developing
`Case 1:22-cv-00252-MSG Document 210-5 Filed 02/02/24 Page 7 of 12 PageID #: 14281
`
`https://www.modernatx.com/en-US/research/product-pipeline
`
`6/11
`
`Moderna rights: Worldwide
`HSV vaccine
`mRNA-1608
`Phase 2
`Moderna rights: Worldwide
`VZV vaccine
`mRNA-1468
`Phase 2
`Moderna rights: Worldwide
`HIV vaccine
`mRNA-1644
`Phase 1
`Moderna rights: Worldwide (IAVI/others funded)
`HIV vaccine
`mRNA-1574
`Phase 1
`Moderna rights: Worldwide (IAVI/BMGF/NIAID and others funded)
`Norovirus vaccine
`mRNA-1403
`Phase 1
`ENTERIC VACCINES
`
`
`1/11/24, 7:35 PM
`
`mRNA medicines we are currently developing
`Case 1:22-cv-00252-MSG Document 210-5 Filed 02/02/24 Page 8 of 12 PageID #: 14282
`
`https://www.modernatx.com/en-US/research/product-pipeline
`
`7/11
`
`Moderna rights: Worldwide
`Norovirus vaccine
`mRNA-1405
`Phase 1
`Moderna rights: Worldwide
`Lyme disease vaccine
`mRNA-1975
`Phase 1
`Moderna rights: Worldwide
`Lyme disease vaccine
`mRNA-1982
`Phase 1
`Moderna rights: Worldwide
`Zika vaccine
`mRNA-1893
`Phase 2
`Moderna rights: Worldwide (BARDA funded)
`Nipah vaccine
`mRNA-1215
`Phase 1
`BACTERIAL VACCINES
`PUBLIC HEALTH VACCINES
`
`
`1/11/24, 7:35 PM
`
`mRNA medicines we are currently developing
`Case 1:22-cv-00252-MSG Document 210-5 Filed 02/02/24 Page 9 of 12 PageID #: 14283
`
`https://www.modernatx.com/en-US/research/product-pipeline
`
`8/11
`
`Moderna rights: Worldwide (NIH funded)
`Mpox
`mRNA-1769
`Phase 1
`Moderna rights: Worldwide
`THERAPEUTICS
`Relaxin
`mRNA-0184
`Phase 1
`Moderna rights: Worldwide
`PD-L1 | Autoimmune hepatitis
`mRNA-6981
`Preclinical Development
`Moderna rights: Worldwide
`Individualized neoantigen therapy (INT) – adjuvant melanoma
`mRNA-4157
`Phase 3
`Moderna rights: 50-50 global profit sharing with Merck
`SYSTEMIC SECRETED & CELL SURFACE THERAPEUTICS
`CANCER VACCINES & THERAPEUTICS
`
`
`1/11/24, 7:35 PM
`
`mRNA medicines we are currently developing
`Case 1:22-cv-00252-MSG Document 210-5 Filed 02/02/24 Page 10 of 12 PageID #: 14284
`
`γ
`
`https://www.modernatx.com/en-US/research/product-pipeline
`
`9/11
`
`KRAS vaccine
`mRNA-5671
`Phase 1
`Moderna rights: Worldwide
`Checkpoint vaccine
`mRNA-4359
`Phase 1
`Moderna rights: Worldwide
`OX40L/ IL-23/ IL-36
` (Triplet) | Solid tumors/ lymphoma
`mRNA-2752
`Phase 1
`Moderna rights: Worldwide
`Propionic acidemia (PA)
`mRNA-3927
`Phase 2
`Moderna rights: Worldwide
`Methylmalonic acidemia (MMA)
`mRNA-3705
`Phase 2
`Moderna rights: Worldwide
`INTRATUMORAL IMMUNO-ONCOLOGY
`RARE DISEASE INTERCELLULAR THERAPEUTICS
`
`
`1/11/24, 7:35 PM
`
`mRNA medicines we are currently developing
`Case 1:22-cv-00252-MSG Document 210-5 Filed 02/02/24 Page 11 of 12 PageID #: 14285
`
`https://www.modernatx.com/en-US/research/product-pipeline
`
`10/11
`
`Investors
`Newsroom
`Patents
`Media Center
`Partnerships
`Careers
`Innovation Incubator
`Glycogen Storage Disease Type 1a (GSD1a)
`mRNA-3745
`Phase 1
`Moderna rights: Worldwide
`Ornithine transcarbamylase deficiency (OTC)
`mRNA-3139
`Preclinical Development
`Moderna rights: Worldwide
`Phenylketonuria (PKU)
`mRNA-3210
`Preclinical Development
`Moderna rights: Worldwide
`Crigler-Naj ar Syndrome Type 1 (CN-1)
`mRNA-3351
`Investors overview
`News and media 2023
`Media kit
`Patents
`All media
`Blogs
`Videos
`Podcasts
`Strategic collaborators
`Life at Moderna
`People behind the science
`Awards
`Join our team
`New Venture Labs
`
`
`1/11/24, 7:35 PM
`
`mRNA medicines we are currently developing
`Case 1:22-cv-00252-MSG Document 210-5 Filed 02/02/24 Page 12 of 12 PageID #: 14286
`
`https://www.modernatx.com/en-US/research/product-pipeline
`
`11/11
`
`© 2024 Moderna, Inc.
`Terms of use
`Privacy statement
`Cookie Statement
`Contact Moderna
`Sitemap
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
